论文部分内容阅读
目的观察89SrCL2联合唑来膦酸在治疗晚期肺癌多发性骨转移瘤、缓解重度骨痛、改善生活质量等方面的疗效。方法对35例晚期肺癌骨转移瘤中重度疼痛的患者分别用89SrCL2联合唑来膦酸治疗。结果 89SrCL2联合唑来膦酸联合治疗组有效率为91.4%。结论用89SrCL2联合唑来膦酸治疗转移性骨肿瘤,能显著减轻患者中重度疼痛、提高生活质量,是一种有效且较安全、可靠的方法。
Objective To observe the efficacy of 89SrCL2 combined with zoledronic acid in the treatment of multiple bone metastases of advanced lung cancer, relieve severe bone pain and improve quality of life. Methods 35 patients with advanced bone cancer with metastatic disease of moderate to severe pain were treated with 89SrCL2 combined with zoledronic acid. Results 89SrCL2 combined with zoledronic acid combined treatment group was 91.4%. Conclusion 89SrCL2 combined with zoledronic acid in the treatment of metastatic bone tumors can significantly reduce moderate to severe pain and improve quality of life, is an effective and safe and reliable method.